A Study Of The Life Changes Experienced By Patients With Pancreatic Cancer

Study Overview

A Study of the Life Changes Experienced by Patients With Pancreatic Cancer

The purpose of this study is to better understand what types of transitions people with pancreatic cancer face when they receive chemotherapy. Again, this study defines transition as a change in a life situation or a status that causes a change in a person's identity, role, behavior, or personal relationships. Examples of transitions include changes in sleeping habits, anxiety, employment, relationship with a higher power, and treatment goals.

N/A

Pancreatic Cancer

BEHAVIORAL: Measurement of Transitions in Cancer Scale (MOT-CA) Survey
BEHAVIORAL: Distress Thermometer Survey

20-038

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates	Results Reporting Dates	Study Record Updates
First Submitted 2020-06-08	Results First Submitted N/A	Last Update Submitted that met QC Criteria 2025-07-23
First Submitted that Met QC Criteria 2020-06-10	Results First Submitted that Met QC Criteria N/A	Last Update Posted (ACTUAL) 2025-07-24
First Posted (ACTUAL) 2020-06-11	Results First Posted N/A	Last Verified 2025-07

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

Primary Purpose:
N/A

Allocation:
N/A

Interventional Model:
N/A

Masking:
N/A

Arms and Interventions

Participant Group/Arm	Intervention/Treatment
: pancreatic cancer health-illness transition In this prospective longitudinal correlational study, a convenience sample of patients with pancreatic cancer receiving chemotherapy will be asked to report on their health-illness transition experiences and their level of distress.	BEHAVIORAL: Measurement of Transitions in Cancer Scale (MOT-CA) Survey These surveys will take 5-10 minutes to complete at two time-points, T0 (baseline) and T1 (four to six weeks after baseline visit) The patient will again complete the DT and MOT-CA at a chemotherapy treatment or clinic visit, if possible, or via a telepho BEHAVIORAL: Distress Thermometer Survey These surveys will take 5-10 minutes to complete at two time-points, T0 (baseline) and T1 (four to six weeks after baseline visit).The patient will again complete the DT and MOT-CA at a chemotherapy treatment or clinic visit, if possible, or via a telepho

Participant Group/Arm

Intervention/Treatment

: pancreatic cancer health-illness transition

In this prospective longitudinal correlational study, a convenience sample of patients with pancreatic cancer receiving chemotherapy will be asked to report on their health-illness transition experiences and their level of distress.

BEHAVIORAL: Measurement of Transitions in Cancer Scale (MOT-CA) Survey

These surveys will take 5-10 minutes to complete at two time-points, T0 (baseline) and T1 (four to six weeks after baseline visit) The patient will again complete the DT and MOT-CA at a chemotherapy treatment or clinic visit, if possible, or via a telepho

BEHAVIORAL: Distress Thermometer Survey

These surveys will take 5-10 minutes to complete at two time-points, T0 (baseline) and T1 (four to six weeks after baseline visit).The patient will again complete the DT and MOT-CA at a chemotherapy treatment or clinic visit, if possible, or via a telepho

Primary Outcome Measures	Measure Description	Time Frame
Extent of the change experienced by patients with pancreatic cancer	Descriptive statistics will be calculated at both time points using (part A on the MOT-CA) for each of the seven transition domains (physical, emotional, social, spiritual, cancer status, treatment, and approach) at both time points (Time 0 and Time 1).	4 to 6 weeks after baseline

Secondary Outcome Measures	Measure Description	Time Frame

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.

Ages Eligible for Study:
ALL

Sexes Eligible for Study:
18 Years

Accepts Healthy Volunteers:

adult patients 18 years of age and older
primary language listed as English in electronic medical record
biopsy proven diagnosis of pancreatic cancer
within three months after initiating a chemotherapy regimen at the Rockefeller Outpatient Pavilion at MSKCC (patient may have previously received chemotherapy at an outside institution or may have received previous chemotherapy regimens at MSKCC).

previous history of cancer within the past five years, except for non-melanoma skin cancer, ductal carcinoma in situ breast cancer, and thyroid cancer.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Hunter College School of Nursing

Investigators

PRINCIPAL_INVESTIGATOR: Jessica Goldberg, RN, MSN, AGPCNP-BC, ACHPN, Memorial Sloan Kettering Cancer Center

Publications

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

No publications available

Learn

Resources

PatientS

Caregivers

Clinical Trial Record